Shareholder Wei Xuening of Changchun Bcht Biotechnology Co., Ltd. (688276.SH) has reduced his holding by a total of 301,800 shares in the company.
Baike Biological (688276.SH) issued a statement on January 15, 2025, stating that the company has received a letter from shareholder Wei Xueling...
Changchun Bcht Biotechnology (688276.SH) announced that on January 15, 2025, the company received a notice from shareholder Mr. Wei Xuening regarding the implementation results of the reduction plan. The reduction results are as follows: Mr. Wei Xuening reduced his holdings in the company by a total of 301,800 shares through centralized bidding trading, accounting for 0.0730% of the total share capital of the company. As of the disclosure date of this announcement, the time period for this reduction plan has been completed.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
